Arbutus Biopharma (ABUS)
(Delayed Data from NSDQ)
$2.86 USD
-0.03 (-1.04%)
Updated May 14, 2024 04:00 PM ET
After-Market: $2.87 +0.01 (0.35%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.10 | 0.00% |
Earnings Summary
For their last quarter, Arbutus Biopharma (ABUS) reported earnings of -$0.10 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ABUS's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for ABUS
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
ABUS: What are Zacks experts saying now?
Zacks Private Portfolio Services